about
The use of lentinan for treating gastric cancerLentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapyCurcumin and Resveratrol as Promising Natural Remedies with Nanomedicine Approach for the Effective Treatment of Triple Negative Breast Cancerβ-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal DiseaseOral administered particulate yeast-derived glucan promotes hepatitis B virus clearance in a hydrodynamic injection mouse model.Contribution of surface β-glucan polysaccharide to physicochemical and immunomodulatory properties of Propionibacterium freudenreichiiEfficient delivery of antigen to DCs using yeast-derived microparticles.Oral microbe-host interactions: influence of β-glucans on gene expression of inflammatory cytokines and metabolome profile.New approaches to the study of sepsisCandida albicans primes TLR cytokine responses through a Dectin-1/Raf-1-mediated pathwayFicolin-2 and ficolin-3 in women with malignant and benign ovarian tumours.Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes.The use of anchored agonists of phagocytic receptors for cancer immunotherapy: B16-F10 murine melanoma model.Euglena gracilis paramylon activates human lymphocytes by upregulating pro-inflammatory factors.Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases.Purification and partial characterization of a novel β-1,3-endoglucanase from Streptomyces rutgersensis.
P2860
Q24619416-D141C9CA-1698-4F59-82B7-F1A2855063D9Q24635111-60D1C3E1-73C7-4E3B-BB24-DDBCD1FA6581Q26744566-917D9A31-3040-47E8-B1D1-40F6E9847043Q27301038-8BD7D046-3CD5-4A77-BE8B-E598D9AED8A3Q35598073-DB4E84E9-4416-4BF2-A917-5BE1292980DDQ35817091-61D8CE34-F3D1-4B61-99C2-C3A53F7906F0Q36293581-716DDCDA-B62A-46B1-9AC7-99FC80BD2759Q36300000-B0D6A672-AD97-4FB4-BDB5-8AEF67B1D994Q36492375-6F0EEB3F-CBE2-4F2E-9616-201062CD6DA7Q36748239-7168C4D7-BCEA-4129-99A3-F835614F50B9Q37029006-2DD1301F-190F-4129-B428-FAF30D959723Q37394444-1D14002E-C2B0-4F9E-9473-63BC9BF9FFDBQ37472919-37ED769B-C6B7-4180-A2EF-F3511BB5BA4AQ42097636-AD345350-6B03-4851-B304-98B36B500E64Q42705635-F30EF8F0-7736-421F-8D2E-3BFEC838063AQ44044476-5FFC2590-57EB-49FA-BC5A-F2E262A7D0F0
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glucan-immunostimulant, adjuvant, potential drug.
@en
Glucan-immunostimulant, adjuvant, potential drug.
@nl
type
label
Glucan-immunostimulant, adjuvant, potential drug.
@en
Glucan-immunostimulant, adjuvant, potential drug.
@nl
prefLabel
Glucan-immunostimulant, adjuvant, potential drug.
@en
Glucan-immunostimulant, adjuvant, potential drug.
@nl
P2860
P356
P1476
Glucan-immunostimulant, adjuvant, potential drug.
@en
P2093
Vaclav Vetvicka
P2860
P304
P356
10.5306/WJCO.V2.I2.115
P577
2011-02-01T00:00:00Z